Spire Healthcare Group PLC · LSE:SPI
Spire Healthcare — FY2017 Earnings Presentation
34 slides from Spire Healthcare's earnings presentation, 2018
Slide 1: 2017 Financial Year Results Presentation
2017 Financial Year Results Presentation www.spirehealthcare.com
Slide 2: Disclaimer
Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the “Company”) and its subsidiaries (collectively, the “Group”), including with respect to the progress, timing and completi
Slide 3: Agenda
Agenda 2017 Overview 1 Garry Watts, Chairman 2017 Financial Review 2 Andrew Goldsmith, HoF The Spire Opportunity 3 Justin Ash, CEO 3 www.spirehealthcare.com
Slide 4: 2017 Overview
2017 Overview Photo from AR 1 Garry Watts, Chairman 4 www.spirehealthcare.com
Slide 5: Steady 2017 performance and a highly experienced CEO now in role
2017 Overview Steady 2017 performance and a highly experienced CEO now in role A challenging year for Spire but our new CEO has a clear blueprint for growth and investment in the future Senior management changes A challenging year for Spire Another change in NHS in H2 with eReferral flat vs 10
Slide 6: 2017 performance in line with revised guidance
2017 Overview 2017 performance in line with revised guidance Revenue & EBITDA Cashflow, Capex and Net debt Revenue up overall by 0.6% on 2016 to £931.7m, with Excellent cash conversion of EBITDA – 105.6% in 2017, third underlying revenue growth of 1.0% successive year >100% Strong growth in Se
Slide 7: Spire's network and strength
2017 Overview Spire’s network and strength Spire is the largest UK independent hospital group by Revenues and EBITDA, with a comprehensive network of quality healthcare assets and services 69% of 134 operating 39 hospitals, hospitals rated 98% of patients theatres & 11 clinics and 1 “Good” rate “Exc
Slide 8: 2017 Financial Review
2017 Financial Review Photo from AR 2 Andrew Goldsmith, Head of Finance 8 www.spirehealthcare.com
Slide 9: Trading headlines
Financial Trading headlines Review 2017 Key drivers in 2017 delivering performance in line with revised guidance Revenue up overall by 0.6% on 2016 to £931.7m with strong underlying growth in Self-Pay Although In-patient and Daycase admissions fell 1.8% to 269,300, average revenue per case incre
Slide 10: "Underlying" vs "Total"
Financial “Underlying” vs “Total” Review 2017 Spire St Anthony’s – underwent significant cost base restructuring in H1 2017, and NHS local contract losses of £4m Spire Manchester – transitioned from original site to new site during January 2017, and new site in ramp-up phase Spire Nottingham –
Slide 11: Financial highlights
Financial Financial highlights Review 2017 2017 2016 Growth £m £m % Underlying Revenue 881.1 872.1 1.0% Non-Underlying Revenue 50.6 54.3 (6.8)% Group Revenue 931.7 926.4 0.6% 2017 Underlying Revenue mix 2016 Underlying Revenue mix 11 www.spirehealthcare.com
Slide 12: Financial highlights
Financial Financial highlights Review 2017 2017 2016 Growth £m £m % Underlying EBITDA 152.2 159.7 (4.7)% Non-Underlying EBITDA (2.2) 2.3 - Group EBITDA 150.0 162.0 (7.4)% 2017 2016 Underlying EBITDA margin 17.3% 18.3% Non-Underlying EBITDA margin (4.4)% 4.2% EBITDA margin 16.1% 17.5% 12 www.spirehea
Slide 13: Revenue and admissions growth – Underlying
Financial Revenue and admissions growth – Review Underlying Revenues 2017 2016 Underlying Total Group £m £m growth % growth % PMI 394.9 401.1 (1.6)% (0.8)% Self pay 175.4 156.6 12.0% 9.6% NHS 281.2 282.6 (0.5)% (1.9)% Other 29.6 31.8 (6.8)% (6.3)% Total revenues 881.1 872.1 1.0% 0.6% Admissions 2017
Slide 14: NHS revenues analysis – Underlying
Financial NHS revenues analysis – Review Underlying Underlying revenues 2017 2016 Growth % £m £m eReferral 241.9 229.4 5.5% NHS Local Contract 39.2 53.1 (26.2)% NHS total revenues 281.2 282.6 (0.5)% Underlying revenue growth rate H2 2017 H1 2017 H2 2016 % % % eReferral 0.9% 10.2% 15.6% NHS Local Con
Slide 15: Revenue bridge by payor – Underlying
Financial Revenue bridge by payor – Review Underlying Underlying revenues 2016 Volume Rate OPD 2017 £m £m £m £m £m PMI 401.1 (11.9) 6.4 (0.7) 394.9 Self pay 156.6 7.6 8.5 2.7 175.4 NHS 282.6 (4.1) 2.8 (0.1) 281.2 Totals 840.3 (8.4) 17.7 (1.9) 851.5 (Group revenue excl. other revenues) Day case % adm
Slide 16: Trading margin analysis – Underlying
Financial Trading margin analysis – Review Underlying Costs as % revenues - Underlying 2017 2016 % % Clinical staff costs 18.8% 18.1% Direct costs 21.9% 21.7% Medical fees 11.1% 11.7% Cost of sales 51.8% 51.5% Costs as % revenues – Underlying 2017 2016 % % Gross margin 48.2% 48.5% Hospital & corpora
Slide 17: Exceptional costs
Financial Exceptional costs Review Exceptional Costs 2017 £m Paterson settlement and related 28.7 Baddow Treatment Centre 11.1 Hospital Set-Up and Closure Costs 3.4 Strategic Review 3.3 Other 2.2 Total 48.7 Note: Additional to the above, £500k of costs associated with initial phase of achieving GDPR
Slide 18: Cash flow for the period
Financial Cash flow for the period Review 2017 2016 £m £m Operating cash flow before exceptionals and tax 158.4 186.3 Exceptional items (31.3) (5.9) Taxation (3.1) (3.0) Net cash used in investing activities (118.3) (149.9) Net cash used in financing activities (34.4) (38.5) Net increase / (decrease
Slide 19: Cash flow for the period
Financial Cash flow for the period Review 2017 2016 £m £m Operating cash flow before exceptionals and tax 158.4 186.3 EBITDA 150.0 162.0 Cash conversion of EBITDA 105.6% 115.0% 19 www.spirehealthcare.com
Slide 20: The Spire Opportunity
The Spire Opportunity Photo from AR 3 Justin Ash, Chief Executive Officer 20 www.spirehealthcare.com
Slide 21: What you will hear today
The Spire What you will hear today Opportunity Sector Vision Outlook Opportunity & Spire for for for today Spire 2018 2022 21 www.spirehealthcare.com
Slide 22: Independent Sector today
The Spire Independent Sector today Opportunity The sector opportunity is substantial and Spire now has the strategy to seize it Demand for UK healthcare provision will continue to rise rapidly NHS waiting lists (especially for elective work), rationing and restrictions are growing Increasingly
Slide 23: Spire today
The Spire Spire today Opportunity Spire is well run – and will benefit from stronger operational focus Overall Growth Well run, good hospital infrastructure Good Self-Pay growth; Improvement Well funded/cash generative potential Operational upside NHS well-managed in volatile market
Slide 24: Our Vision for Spire – Achievement of excellence
The Spire Our Vision for Spire – Opportunity Achievement of excellence “To become the go-to UK independent healthcare brand, famous for clinical quality and customer care” 24 www.spirehealthcare.com
Slide 25: Our Vision for Spire – Strategic goals and Key enablers
The Spire Our Vision for Spire – Opportunity Strategic goals and Key enablers Strategic goals Key enablers Become Famous for Quality & Clinical Care Become Best Place to Practise Drives referrals and customer Consultant supply drives growth perception Become Best Place to Work Most Recom
Slide 26: Our Vision for Spire – Outcomes
The Spire Our Vision for Spire – Opportunity Outcomes What clinical and operational excellence will deliver Leadership in clinical quality and customer care Growth through Private Lower Capex, focus on developing & optimising existing sites More consistent and reliable performance Improved
Slide 27: Payor groups - Medium term outlook & goals
The Spire Payor groups - Opportunity Medium term outlook & goals NHS PMI Self-Pay Market: cost management/ Market: volumes likely flat or Market: growth to continue, triage by Trusts will reduce slightly down, with increase in with consumer demand rising overall market; although Average Revenue Per
Slide 28: New hospitals - 2018 outlook
The Spire New hospitals - Opportunity 2018 outlook Spire Manchester Spire St Anthony’s Spire Nottingham CQC inspection awaited “Good” CQC now CQC report awaited awarded Improve consultant Target key new support, attract new Re-engineered clinical consultants consultants staff cost base
Slide 29: Changes in Capex focus
The Spire Changes in Opportunity Capex focus 2018 2019 onwards Complete commitments; invest in Private Investment in existing estate Total 2018 Capex budget of £100m Upgrade of Private environment and (net) (2017: £120m) assets (e.g. diagnostics) Continuous upgrade Capex of c.£55m, Capacity
Slide 30: Outlook for Financial Year 2018
The Spire Outlook for Opportunity Financial Year 2018 Full year 2018 EBITDA outcome expected to be in line with 2017 Payor group expectations for 2018: Self-Pay: Continued strong growth PMI: Broadly flat NHS: eReferral flat (including tariff effect), Local Contract work further declines from
Slide 31: Measuring Spire's Strategic Vision
The Spire Measuring Spire’s Opportunity Strategic Vision Key priority Measure 2017 Actual 2022 Vision Famous for Good/Outstanding 69% 100% Clinical Quality PHIN data quality N/A Leading sector Most Friends & Family 98% 100% Recommended “Extremely likely” 85% 95% First Choice for Self-Pay Growth 12%
Slide 32: Spire's 2022 Vision
The Spire Spire’s Opportunity 2022 Vision Clinical Quality/ Annual Private Customer Care EBITDA revenues = = = 100% £200m 80% of total 32 www.spirehealthcare.com
Slide 33: Questions
Questions 33 www.spirehealthcare.com
Slide 34: 2017 Financial Year Results Presentation
2017 Financial Year Results Presentation www.spirehealthcare.com
Spire Healthcare Group — FY2017 Earnings Presentation on 6ix